Clinical trial
Open-Label Treatment With MPC-7869 for Patients With Alzheimer's Who Previously…
NCT00380276 · Myrexis Inc., Industry · Terminated
Key facts
| NCT number | NCT00380276 |
|---|---|
| Title | Open-Label Treatment With MPC-7869 for Patients With Alzheimer's Who Previously Participated in an MPC-7869 Protocol |
| Official title | Open Label Study of the Effect of Daily Treatment With MPC-7869 in Subjects With Dementia of the Alzheimer's Type |
| Lead sponsor | Myrexis Inc., Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Alzheimer's Disease |
| Intervention type | Drug |
| Interventions | MPC-7869 |
| Enrollment | 1,000 |
| Start date | Sep 1, 2006 |
| Completion | Dec 1, 2008 |
| First posted | Sep 25, 2006 |
| Last update posted | Aug 5, 2008 |
| Countries | Canada, United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: